<unk> , sold under the brand name Ukoniq, is a medication for the treatment of marginal zone lymphoma (MZL) and follicular lymphoma (FL). It is taken by mouth. The most common side effects include increased creatinine, diarrhea-colitis, fatigue, nausea, neutropenia, transaminase elevation, musculoskeletal pain, anemia, thrombocytopenia, upper respiratory tract infection, vomiting, abdominal pain, decreased appetite, and rash.<unk>  is a kinase inhibitor including PI3K-delta and casein kinase CK1-epsilon.<unk>  was approved for medical use in the United States in February 2021.
Umbralisib
Vagisil
Snoezelen
Tezacaftor
Burapitant
Beractant
Androvax
Furegrelate